Skip to main content
Caplight Logo









Noraker

Noraker

Private
LyonHealthcare & Life Scienceshttps://noraker.com/en

Last Round

Grant

Feb 17, 2022

Total Funding Raised

$5.28M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Noraker is a medical devices company that specializes in the design, manufacturing, and marketing of biomaterial-based implants for bone regeneration and osteosynthesis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

bioactive glassbone graft substitutebone regenerationresorbable biomaterialsbioresorbable implantsosteosynthesissynthetic biomaterialsmedical device manufacturermedtechorthopedic implantsdental bone graftbone void fillerinjectable bone puttycraniomaxillofacial surgeryCMF surgerysports medicine implantscalcium phosphate cement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Noraker Comparables

Compare Noraker with similar companies based on industry and business-model similarity.

Noraker comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BonAlive Biomaterials
89%
Hydrumedical S.A.
86%
Synergy Biomedical, LLC
86%

Noraker Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 17, 2022
GrantNov 1, 2019
SeedDec 1, 2007
Early FundingDec 1, 2006

Key People

Founding team and executive leadership

Celine Saint Olive

CEO

Executive Team

Noraker Investors

Notable investors and investment history

Noraker investors
InvestorRounds
European CommissionGrant
BpifranceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 370% MoM, reaching 969.

  • Feb 21, 2026

    Grew 27% QoQ, from 30 to 38 employees.

Noraker Filings

Explore SEC and related filing metadata, where available.

Noraker filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Noraker's valuation, stock price, and market status.

Is Noraker a public or private company?

Noraker is a private company.

What is the current stock price of Noraker?

Noraker is a private company, so its shares have no public market price. Caplight tracks Noraker's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Noraker worth (valuation)?

Valuation information for Noraker is not publicly available.

Can I buy Noraker stock?

Noraker shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Noraker's last funding round?

Noraker's most recent funding round was Grant on February 17, 2022.

Who are the main investors in Noraker?

Key investors in Noraker include European Commission, Bpifrance.

Will Noraker IPO soon?

No public IPO plans have been announced for Noraker.

How can I track Noraker secondary market activity?

Caplight tracks bids, offers, and trades in Noraker's shares on secondary markets.

Firmographic Details

HeadquartersLyon
Employee Range32
Year Founded2005
Last FundingFeb 17, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?